GB2414394A - Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour - Google Patents
Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour Download PDFInfo
- Publication number
- GB2414394A GB2414394A GB0516981A GB0516981A GB2414394A GB 2414394 A GB2414394 A GB 2414394A GB 0516981 A GB0516981 A GB 0516981A GB 0516981 A GB0516981 A GB 0516981A GB 2414394 A GB2414394 A GB 2414394A
- Authority
- GB
- United Kingdom
- Prior art keywords
- polyoxyethylene
- ionic surfactant
- catamenial tampon
- tampon
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
- A61F13/202—Catamenial tampons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2074—Tampons, e.g. catamenial tampons; Accessories therefor impregnated with hydrophobic, hydrophilic, skin enhancers, medicinal etc. substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/48—Surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/244—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing sulfur or phosphorus
- D06M13/248—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing sulfur or phosphorus with compounds containing sulfur
- D06M13/256—Sulfonated compounds esters thereof, e.g. sultones
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/46—Compounds containing quaternary nitrogen atoms
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/53—Polyethers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Textile Engineering (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Use of a non-ionic surfactant for the treatment of vaginal malodour, wherein the non-ionic surfactant is applied to a catamenial tampon. The preferred non-ionic surfactants are polyoxyethylene, polyoxyethylene stearic acid, polyoxyethylene 40 hydrogenated castor oil, alkanolamide, isostearyl alcohol, glycerol mono/dioleate, glycerol mono/distearate, ethoxylated linear alcohols, PEG-2 stearate, polyoxyalkylated isostearyl alcohol, polyoxyethylene sorbitan monostearate, triglycerol mono-oleate, polysorbate 80, glyceryl monostearate, diglyceryl di-isostearate, polyoxyethylene 20, polyoxyethylene 20 sorbitan mono-oleate, silicone glycol copolymer, polyglyceryl ester, glycol distearate, ethoxylated alcohol, glycol ester and combinations thereof. The preferred non-ionic surfactant is polyoxyethylene 20. The tampon is made of a fibrous material and the non-ionic surfactant is disposed thereon/therein and is able to adsorb malodour associated with body fluids.
Description
:t rib
FIBROUS ABSORBENT ARTICLES HAVING MALODOR
COUNTERACTANT
24 1 4394
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to fibrous absorbent articles having a surface active agent with odor adsorbing properties. More particularly, the present invention relates to fibrous absorbent articles with at least one surface active agent that has the ability to adsorb onto surfaces or interfaces to alter the surfaces or interracial free energy of the interfaces of the fibrous absorbent articles, where the interracial free energy is defined as the force needed to oppose the pull of the molecules in the surface or 1 5 interface.
2. Description of the Prior Art
A variety of proposals have been made in the past as a way to counteract menstrual odors. Such proposals include the use of perfumes to mask the odors that emanate from the absorbent article. Other proposals include the use of substances to suppress or remove odoriferous compounds that may be generated in the presence of menstrual fluids and the like. These odoriferous compounds may be suppressed by a number of mechanisms including forming a non-odoriferous compound by chemical reaction or by absorption of the odoriferous compounds into a solid or liquid. For an absorbent to be effective in deodorizing, especially for odors from body fluids that are characterized as having very low olfactory thresholds, it is essential that the sorbent be capable of removing, in its environment, virtually all the odoriferous compounds regardless of the concentration thereof. :
In order to provide a full background for the present invention reference may be made to U.S. Patent Nos. 3,948,257; 4,795,482; 4,826,497; 5,364,380; and also Registration Hl579.
U.S. Patent No. 3,948,257 is directed to a vulva deodorant system comprising a tampon for insertion into the vagina and a device for retaining a deodorant. The device includes a deodorant in the form of a perfume, powder or the like.
U.S. Patent No. 4,795,482 is directed to a process for eliminating odors and compositions for use therein. The method involves reducing the odors below olfactory detection by contact of the odor producing species with a synthetic crystalline siliceous molecular sieve material.
U.S. Patent No. 4,826,497 provides fibrous absorption articles having enhanced deodorizing properties by having disposed therein an effective amount of crystalline siliceous molecular sieve having pore diameters of at least about 5.5 angstroms and a relatively low capacity for adsorbed water. In addition, this patent provides for the inclusion of zeolite particles having a size of less than about 20 micrometers in the deodorizing sieve. The particles are positioned between the exterior surface of the fluid permeable cover of the absorbent article and a baffle provided within the article.
U.S. Patent No. 5,364,380 provides an absorbent article having a first surface facing the body of a user and a second surface aligned approximately opposite to the first surface. There is also provided a iiquid impermeable baffle and a fluid-permeable cover positioned adjacent to the respective surfaces. In addition, a deodorizing mixture is positioned in the article to remain dry for a substantial period of time. The mixture is an anhydrous, non-buffer blend of at least basic and pH neutral odor adsorbing particles.
Registration Hl579 provides zeolites having "intermediate" SiO2/AI203 ratios used in catamenials, diapers and the like to control odors.
Such intermediate ratios are described as typically in the range from about 2 to about 10.
It may be the case that when applied appropriately there are particular benefits and advantages to the several inventions described in the aforesaid patents. However, it will be apparent that the present invention provides a key advantage not found In prior art What has been discovered and recognized is that the fibrous absorbent articles with the at least one surface active agent of the present invention have the capacity to adsorb odoriferous organic molecules on or in the fibrous absorbent article and in the bodily fluid in the vagina As a result, malodor is controlled and/or eliminated.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a fibrous absorbent catamenial article or product, such as a tampon, that can be reliably and inexpensively produced and that will efficiently adsorb odors associated with menstrual fluid.
It is another object of the present invention to provide such a tampon having at least one surface active agent with odor adsorbing properties.
It is yet another object of the present invention to provide such a tampon where the at least one surface active agent adsorbs onto the surface or interface to alter the surface or interracial free energy of the interface, resulting in odor adsorption.
It is a further object of the present invention to provide a method of incorporating the at least one surface active agent into a tampon. l
The above and other objects and advantages of the present invention are achieved by a tampon or similar device or product in which there is disposed at least one surface active agent. Briefly stated, a broad feature of the present invention is a fibrous absorbent article for absorbing body fluids made up of a fibrous material defining a structure suitable for absorbing the body fluids, and disposed in or on the structure, an effective amount of at least one surface active agent, so as to adsorb malodor associated with these bodily fluids.
Other and further objects, advantages and features of the present invention will be understood by reference to the following description.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is directed to a fibrous absorbent article, such as a tampon or feminine pad, with at least one surface active agent disposed on or in the fibrous absorbent article. The at least one surface active agent has the property of adsorbing onto surfaces or interfaces to alter the surface or interracial free energies of the interface. The term "interface", as used herein, refers to a boundary between phases including, but not limited to, liquid-liquid phase boundaries, liquidsolid phase boundaries, liquid-gas phase boundaries, and gas-solid phase boundaries.
When vaginal malodor compositions come into contact with a fibrous absorbent article, such as a tampon, the phase boundary area between the malodor and fiber surface is large relative to the volume of the system.
Therefore, the total mass of the system is present at the boundaries The behavior of the fiber system is determined to a large degree by the interracial processes. The at least one surface active agent can play an important role in the process. Surface active agents have a molecular structure with a structural group that has little attraction for the solvent phase (Iyophobic) and a group that has a strong attraction for the solvent phase (Iyophilic). When surface active agents are added to the surface of : fibers of a tampon, the presence of the Iyophobic group causes a distortion of the solvent liquid structure, thus increasing the free energy of the system. In the presence of an aqueous solution of a surface active agent, this distortion of the malodor (water) phase by the Iyophobic group, and the resulting increase in the free energy of the system, results in less energy required to bring a surface active agent, rather than a water molecule, to the surface. Therefore, the at least one surface active agent concentrates on the surface of the fibrous absorbent article.
The presence of the Iyophilc group prevents the surface active agent from being expelled from the solvent phase. As a result, the surface active agent concentrates at the surface and orients itself so that the hydrophilic group is in the aqueous phase (malodor phase) and the hydrophobic group is oriented away from the aqueous phase. The malodorous components are therefore chemically bound (ionic and/or covalent) by the surface active agents onto the surface at the fiber-liquid interface.
The chemical structure of the at least one surface active agent suitable for this application can vary with the nature of the fiber chemistry, malodor phase and the conditions of use. In the presence of a polar solvent phase such as vaginal malodor, ionic or highly polar groups may act as the Iyophilic groups. In the presence of electrolytes or organic additives as in vaginal malodor, several surface active agents may be needed to maintain surface activity at a suitable level. For surface activity (adsorption of malodor) to be effective, the at least one surface active agent molecule must have a chemical structure that is amphipathic in the malodor phase under the conditions of use.
Suitable surface active agents for use with the present invention include, but are not limited to, one or more surfactants, polymers, or any combinations thereof.
Suitable surfactants include, but are not limited to, one or more anionic, nonionic, cationic, amphoteric, silicone-based, polymeric, or any combinations thereof.
Suitable anionic surfactants that may be used in the present invention include, but are not limited to, sodium alkyl aryl ethoxy sulfate, alkylalkoxylated phosphate ester sodium salt, dioctylester of sodium sulfosuccinic acid, dioctyl sulfosuccinate, ammonium salt of polycarboxylic acid, potassium salt of complex organic phosphate ester, ammonium lauryl ether sulfate, or any combinations thereof.
Suitable nonionic surfactants that may used in the present invention include, but are not limited to, polyoxyethylene, polyoxyethylene stearic acid, polyoxyethylene 40 hydrogenated castor oil, alkanolamides, isostearyl alcohol, polyoxyethylene /polyoxypropylene block copolymer, glycerol mono/dioleate, glycerol mono/distearate, ethoxylated linear alcohols (50% ethoxylated). PEG-2 stearate, polyoxyalkylated isostearyl alcohol, polyoxyethylene sorbitan monostearate, triglycerol monooleate, polysorbate 80, glyceryl monostearate, diglyceryl diisostearate, polyoxyethylene 20, polyoxyethylene 20 sorbitan monooleate, silicone glycol copolymer, polyglyceryl ester, glycol distearate, ethoxylated alcohols (Ceteareth-20), glycol esters (PEG 400 ditallate), or any combinations thereof.
Suitable cationic surfactants that may be used in the present invention include, but are not limited to, trimethyl coco quaternary ammonium chloride, distearyl dimonium chloride, benzalkonium chloride, benzethonium chloride, or any combinations thereof.
Suitable amphoteric surfactants that may be used in the present invention include, but are not limited to, coconut-based (imidazoline, dicarboxylate, sodium salt), coco amido betaine, betaine derivatives (oleyl betaine), octyl dipropionate, cocamphoglycinate, or any combinations :: /: thereof.
Suitable silicone-based surfactants that may be used in the present invention include, but are not limited to, cetyl dmethicone copolyol, dialkoxy dimethyl polysiloxane, polysiloxane polyalkyl copolymers, or any combinations thereof.
Suitable polymer that may be used in the present invention Includes, but is not limited to, acrylates/C10-30 alkyl acrylate crosspolymer.
In order to achieve the odor adsorption properties of the present invention, the at least one surface active agent is present in an amount about 0.001 percentage by weight (wt.%) to about 30 wt % and preferably about 0.01 wt.% to about 5 wt.%, based on the total weight of the fibrous absorbent article.
The following example demonstrates the effectiveness of the use of a surface active agent on a tampon to reduce and/or eliminate malodor.
A study was conducted to identify and rate the aroma attributes and intensities of malodor treated non-deodorant tampons with varying levels/types of malodor adsorbing/neutralizing treatments, including one with a surface active agent according to the present invention.
Samples were prepared using unscented tampons according to a detailed protocol. Each sample included a 15% malodor applied to the unscented tampon. The samples prepared are indicated below in Table 1.
The samples in Table 1 were prepared and tested on three separate occasions.
Table 1. Samples
Sample A - Non-deodorant tampon + 15% malodor solution Sample B - Nondeodorant tampon + 15% malodor solution + zeolite (0.7 wt.% to 2.63 wt.%) Sample C - Non-deodorant tampon + 15% malodor solution + glycerin (0.92 wt.% to 3.61 wt.%) Sample D - Non-deodorant tampon + 15% malodor solution + glycerin (0.92 wt.% to 1.81 wt.%) + polyoxyethylene (20) (0 64 wt.% to 1.25 wt.%) Evaluation of the samples was performed in a well-ventilated room having an exhaust fan available. Five objective sensory experts, trained experienced, and calibrated in aroma analysis, evaluated the samples on the date of receipt. Each panelist received a complete set of samples with the control and non-deodorant products. All panelists evaluated a sample at the same time, and consensus results of the characteristics and intensities were recorded. Panelists waited at least 30 minutes between evaluations and were allowed to smell a neutral substrate (paper napkin or back of arm) between and within samples as needed to prevent acclimating to the malodor or fragrance. For each session, one sample was randomly repeated as a check of intensity results. The repeated sample was generally one for which variable results were detected within jar from a single sample treatment.
The intensity of the sensory characteristics were rated on a 15 point intensity scale with 0 = none and 15 = very strong. Data is reported as consensus data. It is noted that panelists are able to see small differences and can often detect aroma differences as small as 0.2 units on the 15 point scale used. Panelists commonly detect differences of 0.5 units.
Table 2 provides mean results over three replications. When reviewing Table 2, it is noted that for attributes having a range in intensity across jars within a sample, the highest values were used to calculate means.
Table 2. Non-Deodorant Samples - Mean Profiles Sample A Sample B Sample C Sample D
MEAN MEAN MEAN MEAN
_
Malodor Intensity 6 0 5.9 5 3 4.9 Isovaleric 1.7 2.0 2.0 1.8 Ammonia 2. 4 2.0 1.8 2.0 Degraded Protein 2.5 2.5 2.3 1.8 Ferric 1.0 1.0 1.0 0.9 Popcorn/Paper 0.0 0.2 0.0 0.3 Sulfite/Paper 0.8 0.0 0.0 0.3 As is evident from Table 2, Sample D, with the surface active agent according to the present invention, exhibited the lowest overall malodor intensity of the samples tested.
The at least one surface active agents may be incorporated in a fibrous absorbent article in any of the following methods, including but not limited to, application during fiber processing, post-processing fiber surface treatment, deposited on the inside of the article, applied to the exterior of the article, included in a coverstock material, included in the removal string or other removal device, included as part of the applicator, encapsulated and applied in above-referenced ways, or any combinations thereof.
Application methods may include but are not limited to spraying of surfactant in a patterned or random arrangement, deposited in droplets, or any combinations thereof.
The present invention having been thus been described with particular reference to the preferred forms thereof, it will be obvious that various changes and modifications may be made therein without departing from the spirit and scope of the present invention as defined in the appended claims.
Claims (5)
1. Use of a non-ionic surfactant in the manufacture of a medicament for the treatment of vaginal malodour, wherein the non-ionic surfactant is applied to a catamenial tampon.
2. Use according to Claim 1, wherein the non-ionic surfactant is selected from the group consisting of polyoxyethylene, polyoxyethylene stearic acid, polyoxyethylene 40 hydrogenated castor oil, alkanolamide, isostearyl alcohol, glycerol mono/dioleate, glycerol mono/diste5arate, ethoxylated linear alcohols, PEG-2 stearate, polyoxyalkylated isostearyl alcohol, polyoxyethylene sorbitan monostearate, triglycerol monooleate, polysorbate 80, glyceryl monostearate, diglyceryl diisostearate, polyoxyethylene 20, polyoxyethylene 20 sorbitan monooleate, silicone glycol copolymer, polyglyceryl ester, glycol distearate, ethoxylated alcohol, glycol ester, and any combinations thereof.
3. Use according to Claim 1 or Claim 2, wherein the non-ionic surfactant is present in the catamenial tampon in an amount of between 0.001 % and % by weight of the total weight of the fibrous catamenial tampon.
4. Use according to Claim 3, wherein the non-ionic surfactant is present in the catamenial tampon in an amount of between 0.01% and 5 % by weight of the total weight of the fibrous catamenial tampon.
5. Use according to Claim 4, wherein the non-ionic surfactant is present in the catamenial tampon in an amount of between 0.64% and 1.25 % by weight of the total weight of the fibrous catamenial tampon.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28307901P | 2001-04-11 | 2001-04-11 | |
US10/120,044 US8093446B2 (en) | 2001-04-11 | 2002-04-10 | Fibrous absorbent articles having malodor counteractant |
GB0324391A GB2392452B (en) | 2001-04-11 | 2002-04-11 | Fibrous absorbent articles having malodor counteractant |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0516981D0 GB0516981D0 (en) | 2005-09-28 |
GB2414394A true GB2414394A (en) | 2005-11-30 |
GB2414394B GB2414394B (en) | 2006-01-11 |
Family
ID=34922957
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0514213A Expired - Fee Related GB2412121B (en) | 2001-04-11 | 2002-04-11 | Tampon with malodour counteractant |
GB0516981A Expired - Fee Related GB2414394B (en) | 2001-04-11 | 2002-04-11 | Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour |
GB0514212A Withdrawn GB2412120A (en) | 2001-04-11 | 2005-07-11 | Fibrous tampon with a anionic surfactant as a malodour counteractant |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0514213A Expired - Fee Related GB2412121B (en) | 2001-04-11 | 2002-04-11 | Tampon with malodour counteractant |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0514212A Withdrawn GB2412120A (en) | 2001-04-11 | 2005-07-11 | Fibrous tampon with a anionic surfactant as a malodour counteractant |
Country Status (1)
Country | Link |
---|---|
GB (3) | GB2412121B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015140072A1 (en) * | 2014-03-19 | 2015-09-24 | Bauerfeind Ag | Fibres and yarns with blocking function |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727208B2 (en) | 2002-09-12 | 2010-06-01 | Playtex Products, Inc. | Ergonomic tampon applicator |
US9192522B2 (en) | 2003-05-02 | 2015-11-24 | Eveready Battery Company, Inc. | Tampon assembly having shaped pledget |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061145A (en) * | 1975-11-26 | 1977-12-06 | The Procter & Gamble Company | Absorbent foam articles and method of manufacture |
WO1999012505A2 (en) * | 1997-09-11 | 1999-03-18 | Brigham And Women's Hospital | Absorbent article having additives that reduce toxic shock |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US453098A (en) * | 1891-05-26 | Baling-press | ||
GB883765A (en) * | 1958-11-12 | 1961-12-06 | Alginate Ind Ltd | Improvements in or relating to alginic compounds |
NO178843C (en) * | 1988-07-11 | 1996-06-19 | Sspl Sa Safe Sex Prod Licens | Process for the preparation of a pharmaceutical composition for the prevention of sexually transmitted diseases |
-
2002
- 2002-04-11 GB GB0514213A patent/GB2412121B/en not_active Expired - Fee Related
- 2002-04-11 GB GB0516981A patent/GB2414394B/en not_active Expired - Fee Related
-
2005
- 2005-07-11 GB GB0514212A patent/GB2412120A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061145A (en) * | 1975-11-26 | 1977-12-06 | The Procter & Gamble Company | Absorbent foam articles and method of manufacture |
WO1999012505A2 (en) * | 1997-09-11 | 1999-03-18 | Brigham And Women's Hospital | Absorbent article having additives that reduce toxic shock |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015140072A1 (en) * | 2014-03-19 | 2015-09-24 | Bauerfeind Ag | Fibres and yarns with blocking function |
CN106460236A (en) * | 2014-03-19 | 2017-02-22 | 鲍尔法因德股份有限公司 | Fibres and yarns with blocking function |
EP3640377A1 (en) * | 2014-03-19 | 2020-04-22 | Bauerfeind AG | Fibers and yarns with pain-reducing active substance |
US10851477B2 (en) | 2014-03-19 | 2020-12-01 | Bauerfeind Ag | Fibers and yarns with blocking function |
CN113529193A (en) * | 2014-03-19 | 2021-10-22 | 鲍尔法因德股份有限公司 | Fibres and yarns with barrier effect |
Also Published As
Publication number | Publication date |
---|---|
GB0516981D0 (en) | 2005-09-28 |
GB2412120A (en) | 2005-09-21 |
GB0514213D0 (en) | 2005-08-17 |
GB2412121A (en) | 2005-09-21 |
GB0514212D0 (en) | 2005-08-17 |
GB2414394B (en) | 2006-01-11 |
GB2412121B (en) | 2006-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8093446B2 (en) | Fibrous absorbent articles having malodor counteractant | |
KR100356081B1 (en) | Doped odour controlling materials | |
US7578997B2 (en) | Metal ion modified high surface area materials for odor removal and control | |
JP3753581B2 (en) | Absorbent articles | |
US7799966B2 (en) | Fibrous absorbent articles having malodor counteractant ability and method of making same | |
KR100982839B1 (en) | Absorbent Resin Composition | |
JP3964685B2 (en) | Absorbent articles that reduce urine odor | |
GB2414394A (en) | Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour | |
GB2415626A (en) | Fibrous tampon with a cationic surfactant as a malodour counteractant | |
US20050008608A1 (en) | Odor-mitigating compositions | |
CN118217435A (en) | Filter | |
JP2002291805A (en) | Absorbable article | |
JPS6377452A (en) | Aromatic deodorizing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20150411 |